Hydrogenology
Hydrogenology editorial study record

Hydrogen alleviates hypoxic-ischaemic brain damage in neonatal rats by inhibiting injury of brain pericytes.

Li H, Sun H, Li S, Huang L, Zhang M, Wang S, Liu Q, Ying J, Zhao F, Su X, Mu D, Qu Y. · 2024.

PreclinicalH₂-rich waterPublished 2024
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled neonatal-rat and pericyte study

Research topic

Other neurological conditions

Administration classification

H₂-rich water

Study result signal

Positive preclinical signal.

Outcome type

Animal functional, tissue and mechanistic cell outcomes.

Reported in the source

Methods at a glance

Population or model

Neonatal rats with hypoxic-ischemic brain injury and oxygen-glucose-deprived brain pericytes.

Sample

Animal and cell groups with assay-specific counts reported in the full article.

Duration

Acute neonatal-injury and cell-exposure protocol.

Intervention

Different doses of hydrogen-rich water in vivo and different concentrations in cultured pericytes.

Hydrogen form

H₂ dissolved in water or culture medium.

H₂ specification

Dose- and concentration-specific conditions are reported in the article.

H₂ flow

Not applicable.

O₂ delivered with H₂

No oxygen was co-delivered as part of the H₂ intervention.

Comparator

Injury controls, hydrogen doses and cell-death inhibitor comparisons.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Neurological function, cerebrovascular and tissue injury, oxidative stress, pericyte death and Nrf2/HO-1 signaling.

Reported result

Hydrogen-rich water was reported to reduce pericyte oxidative injury and several cerebrovascular, tissue and functional injury measures in the tested models.

Results-extraction completeness

The full article was checked for methods, intervention details, outcomes, positive and null findings, funding and conflicts. This record does not imply medical efficacy.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Preclinical evidence only; multiple doses, cell-death pathways and correlated endpoints.

Applies directly to

The reported neonatal-rat and pericyte models only.

Preliminary appraisal framework

SYRCLE animal-study tool — preliminary

Preliminary risk-of-bias status

Some concerns

Appraisal rationale

Controls were used, but allocation concealment, blinded assessment and multiplicity handling were not fully established.

Appraisal domains

Sequence generation checked where reported · Allocation concealment generally unclear · Personnel blinding generally unclear · Outcome-assessor blinding generally unclear · No prospectively registered analysis plan identified

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 39001579 · DOI: 10.1111/jcmm.18505

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official PubMed Central full article and PubMed bibliographic record; source identity, methods, intervention, results, funding and conflicts checked 10 August 2026.

Record revision

2026-08-10